Specifically, genetic testing is recommended for individuals with a familial predisposition to FVL, families with a documented history of thrombophilia, patients who have received a diagnosis of antiphospholipid syndrome, or individuals requiring anticoagulant therapy. The gene discussed is F5; the disease is thrombophilia.